​

Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTRA Stock Forecast

Natera (NTRA) stock forecast, based on 28 Wall Street analysts, predicts a 12-month average price target of $386.00, with a high of $500.00 and a low of $245.00. This represents a 6.11% increase from the last price of $363.76.

$150 $220 $290 $360 $430 $500 High: $500 Avg: $386 Low: $245 Last Closed Price: $363.76

NTRA Stock Rating

Natera stock's rating consensus is Buy, based on 28 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (89.29%), 3 Hold (10.71%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 28 0 3 25 Strong Sell Sell Hold Buy Strong Buy

NTRA Price Target Upside V Benchmarks

TypeNameUpside
StockNatera6.11%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks5.60%

Price Target Trends

1M3M12M
# Anlaysts51938
Avg Price Target$463.00$393.79$332.00
Last Closing Price$363.76$363.76$363.76
Upside/Downside27.28%8.26%-8.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 264172--23
Oct, 265162--23
Sep, 265143--22
Aug, 265143--22
Jul, 265143--22
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 06, 2026Dave WestenbergPiper Sandler$363.50$310.6817.00%-0.07%
Oct 27, 2026Mark MassaroBTIG$430.00$404.906.20%18.21%
Oct 22, 2026Roth Capital$475.00$401.3718.34%30.58%
Oct 19, 2026Canaccord Genuity$500.00$393.4427.08%37.45%
Oct 12, 2026Morgan Stanley$435.00$400.648.58%19.58%
Oct 07, 2026Barclays$475.00$400.6518.56%30.58%
Oct 01, 2026Guggenheim$475.00$418.1213.60%30.58%
Sep 25, 2026RBC Capital$460.00$409.7012.28%26.46%
Sep 09, 2026UBS$435.00$324.1434.20%19.58%
Sep 08, 2026Redburn Partners$385.00$328.1817.31%5.84%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2026Piper SandlerOverweightOverweighthold
Oct 27, 2026BTIGBuyBuyhold
Oct 22, 2026Roth CapitalBuyinitialise
Oct 13, 2026Cowen & Co.BuyBuyhold
Oct 12, 2026Morgan StanleyOverweightOverweighthold
Oct 07, 2026BarclaysOverweightOverweighthold
Oct 06, 2026CitigroupBuyBuyhold
Oct 01, 2026GuggenheimBuyBuyhold
Sep 25, 2026RBC CapitalOutperformOutperformhold
Sep 08, 2026RBC CapitalOutperformBuyupgrade

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.21$-5.57$-3.78$-1.53$-1.52---
Avg Forecast$-5.02$-5.60$-3.96$-1.50$-1.20$0.02$0.98$1.46
High Forecast$-4.90$-5.26$-3.87$-1.22$-0.79$0.37$2.21$1.53
Low Forecast$-5.32$-5.85$-4.05$-1.61$-1.51$-0.15$0.18$1.33
Surprise %3.78%-0.54%-4.55%2.00%26.67%---

Revenue Forecast

$500M $1B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$625.49M$820.22M$1.08B$1.70B$2.31B---
Avg Forecast$621.43M$819.43M$1.07B$1.65B$1.82B$2.14B$2.46B$2.68B
High Forecast$650.44M$846.85M$1.09B$1.66B$1.88B$2.15B$2.46B$2.79B
Low Forecast$610.12M$780.38M$1.06B$1.64B$1.78B$2.14B$2.45B$2.50B
Surprise %0.65%0.10%1.17%2.72%26.80%---

Net Income Forecast

$-600M $-420M $-240M $-60M $120M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-471.72M$-547.80M$-434.80M$-190.43M$-208.16M---
Avg Forecast$-398.29M$-395.34M$-499.34M$-162.83M$-145.21M$33.61M$168.67M$167.89M
High Forecast$-318.63M$-316.27M$-399.47M$-140.20M$-90.38M$42.22M$253.93M$176.39M
Low Forecast$-477.94M$-474.40M$-599.21M$-185.46M$-173.31M$-17.72M$20.83M$152.77M
Surprise %18.44%38.57%-12.93%16.95%43.35%---

NTRA Forecast FAQ

Is Natera stock a buy?

Natera stock has a consensus rating of Buy, based on 28 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Natera is a favorable investment for most analysts.

What is Natera's price target?

Natera's price target, set by 28 Wall Street analysts, averages $386 over the next 12 months. The price target range spans from $245 at the low end to $500 at the high end, suggesting a potential 6.11% change from the previous closing price of $363.76.

How does Natera stock forecast compare to its benchmarks?

Natera's stock forecast shows a 6.11% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (5.60%).

What is the breakdown of analyst ratings for Natera over the past three months?

  • November 2026: 17.39% Strong Buy, 73.91% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 21.74% Strong Buy, 69.57% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 22.73% Strong Buy, 63.64% Buy, 13.64% Hold, 0% Sell, 0% Strong Sell.

What is Natera’s EPS forecast?

Natera's average annual EPS forecast for its fiscal year ending in December 2026 is $0.02, marking a -101.32% decrease from the reported $-1.52 in 2025. Estimates for the following years are $0.98 in 2027, and $1.46 in 2028.

What is Natera’s revenue forecast?

Natera's average annual revenue forecast for its fiscal year ending in December 2026 is $2.14B, reflecting a -7.05% decrease from the reported $2.31B in 2025. The forecast for 2027 is $2.46B, and $2.68B for 2028.

What is Natera’s net income forecast?

Natera's net income forecast for the fiscal year ending in December 2026 stands at $33.61M, representing a -116.14% decrease from the reported $-208M in 2025. Projections indicate $168.67M in 2027, and $167.89M in 2028.